22nd Century Expands VLN® Cigarette Distribution as FDA Nicotine Rule Looms

Event summary

  • 22nd Century distributed 8,800 cartons of VLN® cigarettes across 1,700 new U.S. retail outlets in Q4 2025.
  • Company targets 5,000+ retail points by end of 2026 as early sales data shows consumer adoption.
  • FDA proposed January 2025 rule to cap nicotine levels at 0.7mg/g, positioning VLN® as compliant product.
  • VLN® remains the only FDA-authorized combustible cigarette designed to reduce nicotine consumption.

The big picture

22nd Century's expansion comes as global regulators increasingly endorse nicotine reduction as a tobacco control strategy. The company's proprietary low-nicotine technology positions it at the forefront of a potential industry shift, though success depends on maintaining first-mover advantage while navigating evolving regulatory frameworks. The proposed FDA rule represents both an opportunity and validation of 22nd Century's scientific approach.

What we're watching

Regulatory Tailwinds
Whether FDA finalizes nicotine reduction rule and its impact on VLN® market positioning.
Commercial Scaling
Pace of retail expansion and ability to sustain distribution growth across 5,000+ outlets.
Consumer Behavior
Long-term adoption rates among smokers seeking nicotine reduction alternatives.